nodes	percent_of_prediction	percent_of_DWPC	metapath
Agomelatine—HTR2B—Serotonin receptors—HTR2A—conduct disorder	0.043	0.043	CbGpPWpGaD
Agomelatine—HTR2C—Serotonin receptors—HTR2A—conduct disorder	0.0347	0.0347	CbGpPWpGaD
Agomelatine—HTR2B—Monoamine GPCRs—DRD4—conduct disorder	0.0293	0.0293	CbGpPWpGaD
Agomelatine—HTR2B—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.0286	0.0286	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0268	0.0268	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.0268	0.0268	CbGpPWpGaD
Agomelatine—HTR2B—Amine ligand-binding receptors—DRD4—conduct disorder	0.0247	0.0247	CbGpPWpGaD
Agomelatine—HTR2C—Monoamine GPCRs—DRD4—conduct disorder	0.0237	0.0237	CbGpPWpGaD
Agomelatine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.0231	0.0231	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—SLC6A4—conduct disorder	0.0228	0.0228	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—SLC6A4—conduct disorder	0.0228	0.0228	CbGpPWpGaD
Agomelatine—CYP1A2—Methylation—COMT—conduct disorder	0.0216	0.0216	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—DRD4—conduct disorder	0.0214	0.0214	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—DRD4—conduct disorder	0.0214	0.0214	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—CGA—conduct disorder	0.0204	0.0204	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—CGA—conduct disorder	0.0204	0.0204	CbGpPWpGaD
Agomelatine—HTR2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.0199	0.0199	CbGpPWpGaD
Agomelatine—HTR2B—Monoamine GPCRs—HTR2A—conduct disorder	0.0191	0.0191	CbGpPWpGaD
Agomelatine—MTNR1A—G alpha (i) signalling events—DRD4—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Agomelatine—MTNR1B—G alpha (i) signalling events—DRD4—conduct disorder	0.0189	0.0189	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0175	0.0175	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.0175	0.0175	CbGpPWpGaD
Agomelatine—HTR2B—Amine ligand-binding receptors—HTR2A—conduct disorder	0.0161	0.0161	CbGpPWpGaD
Agomelatine—HTR2C—Monoamine GPCRs—HTR2A—conduct disorder	0.0154	0.0154	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.015	0.015	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.015	0.015	CbGpPWpGaD
Agomelatine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.0135	0.0135	CbGpPWpGaD
Agomelatine—HTR2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.013	0.013	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—CGA—conduct disorder	0.0115	0.0115	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—CGA—conduct disorder	0.0115	0.0115	CbGpPWpGaD
Agomelatine—MTNR1B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Agomelatine—MTNR1A—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—DRD4—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—DRD4—conduct disorder	0.0114	0.0114	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—CGA—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—CGA—conduct disorder	0.0105	0.0105	CbGpPWpGaD
Agomelatine—MTNR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00981	0.00981	CbGpPWpGaD
Agomelatine—MTNR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00981	0.00981	CbGpPWpGaD
Agomelatine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00916	0.00916	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00866	0.00866	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR ligand binding—HTR2A—conduct disorder	0.00747	0.00747	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR ligand binding—HTR2A—conduct disorder	0.00747	0.00747	CbGpPWpGaD
Agomelatine—MTNR1A—Circadian rythm related genes—EP300—conduct disorder	0.0074	0.0074	CbGpPWpGaD
Agomelatine—MTNR1B—Circadian rythm related genes—EP300—conduct disorder	0.0074	0.0074	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00699	0.00699	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—CGA—conduct disorder	0.0066	0.0066	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—DRD4—conduct disorder	0.00647	0.00647	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—DRD4—conduct disorder	0.00647	0.00647	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—CGA—conduct disorder	0.0062	0.0062	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—CGA—conduct disorder	0.0062	0.0062	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—DRD4—conduct disorder	0.00587	0.00587	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—DRD4—conduct disorder	0.00587	0.00587	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00566	0.00566	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.00532	0.00532	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—WASF1—conduct disorder	0.00497	0.00497	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—WASF1—conduct disorder	0.00497	0.00497	CbGpPWpGaD
Agomelatine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00486	0.00486	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00485	0.00485	CbGpPWpGaD
Agomelatine—HTR2B—G alpha (q) signalling events—HTR2A—conduct disorder	0.00478	0.00478	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00457	0.00457	CbGpPWpGaD
Agomelatine—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00427	0.00427	CbGpPWpGaD
Agomelatine—MTNR1A—GPCR downstream signaling—HTR2A—conduct disorder	0.00422	0.00422	CbGpPWpGaD
Agomelatine—MTNR1B—GPCR downstream signaling—HTR2A—conduct disorder	0.00422	0.00422	CbGpPWpGaD
Agomelatine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00415	0.00415	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00391	0.00391	CbGpPWpGaD
Agomelatine—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.00386	0.00386	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling by GPCR—HTR2A—conduct disorder	0.00383	0.00383	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling by GPCR—HTR2A—conduct disorder	0.00383	0.00383	CbGpPWpGaD
Agomelatine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.0038	0.0038	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—CGA—conduct disorder	0.00373	0.00373	CbGpPWpGaD
Agomelatine—HTR2B—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00369	0.00369	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—DRD4—conduct disorder	0.00369	0.00369	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—DRD4—conduct disorder	0.00347	0.00347	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—DRD4—conduct disorder	0.00347	0.00347	CbGpPWpGaD
Agomelatine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.00345	0.00345	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—CGA—conduct disorder	0.00339	0.00339	CbGpPWpGaD
Agomelatine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00317	0.00317	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—CGA—conduct disorder	0.00301	0.00301	CbGpPWpGaD
Agomelatine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—DRD4—conduct disorder	0.00298	0.00298	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Agomelatine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00274	0.00274	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—CGA—conduct disorder	0.00273	0.00273	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.0026	0.0026	CbGpPWpGaD
Agomelatine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00258	0.00258	CbGpPWpGaD
Agomelatine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00256	0.00256	CbGpPWpGaD
Agomelatine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00255	0.00255	CbGpPWpGaD
Agomelatine—HTR2B—GPCR ligand binding—HTR2A—conduct disorder	0.00241	0.00241	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—HTR2A—conduct disorder	0.00226	0.00226	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—HTR2A—conduct disorder	0.00226	0.00226	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00222	0.00222	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Agomelatine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00221	0.00221	CbGpPWpGaD
Agomelatine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00219	0.00219	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—DRD4—conduct disorder	0.00209	0.00209	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—CGA—conduct disorder	0.002	0.002	CbGpPWpGaD
Agomelatine—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	0.00194	0.00194	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—DRD4—conduct disorder	0.0019	0.0019	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00189	0.00189	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	0.00168	0.00168	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—CGA—conduct disorder	0.00161	0.00161	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—WASF1—conduct disorder	0.0016	0.0016	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—DRD4—conduct disorder	0.00153	0.00153	CbGpPWpGaD
Agomelatine—HTR2B—GPCR downstream signaling—HTR2A—conduct disorder	0.00136	0.00136	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—WASF1—conduct disorder	0.00129	0.00129	CbGpPWpGaD
Agomelatine—HTR2B—Signaling by GPCR—HTR2A—conduct disorder	0.00124	0.00124	CbGpPWpGaD
Agomelatine—MTNR1B—Signaling Pathways—EP300—conduct disorder	0.0012	0.0012	CbGpPWpGaD
Agomelatine—MTNR1A—Signaling Pathways—EP300—conduct disorder	0.0012	0.0012	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—DRD4—conduct disorder	0.00112	0.00112	CbGpPWpGaD
Agomelatine—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	0.0011	0.0011	CbGpPWpGaD
Agomelatine—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	0.000998	0.000998	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—CGA—conduct disorder	0.000985	0.000985	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—DRD4—conduct disorder	0.000904	0.000904	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—CGA—conduct disorder	0.000842	0.000842	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—HTR2A—conduct disorder	0.000731	0.000731	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—HTR2A—conduct disorder	0.00059	0.00059	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—COMT—conduct disorder	0.000445	0.000445	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000441	0.000441	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000428	0.000428	CbGpPWpGaD
Agomelatine—HTR2B—Signaling Pathways—EP300—conduct disorder	0.000387	0.000387	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—COMT—conduct disorder	0.00038	0.00038	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000377	0.000377	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000366	0.000366	CbGpPWpGaD
Agomelatine—HTR2C—Signaling Pathways—EP300—conduct disorder	0.000312	0.000312	CbGpPWpGaD
Agomelatine—CYP2C9—Metabolism—EP300—conduct disorder	0.000191	0.000191	CbGpPWpGaD
Agomelatine—CYP1A2—Metabolism—EP300—conduct disorder	0.000163	0.000163	CbGpPWpGaD
